National Cancer Institute; Notice of Closed Meetings, 5092-5093 [2010-2030]

Download as PDF 5092 Federal Register / Vol. 75, No. 20 / Monday, February 1, 2010 / Notices Place: Hilton Rockville Executive Meeting Center, 1750 Rockville Pike, Plaza 3 Conference Room, Rockville, Maryland 20850. 4. Name of Subcommittee: Health Care Research Training. Date: March 4–5, 2010 (Open from 8 a.m. to 8:15 a.m. on March 4 and closed for remainder of the meeting). Place: Hilton Rockville Executive Meeting Center, 1750 Rockville Pike, Madison Conference Room, Rockville, Maryland 20850. Contact Person: Anyone wishing to obtain a roster of members, agenda or minutes of the nonconfidential portions of the meetings should contact Mrs. Bonnie Campbell, Committee Management Officer, Office of Extramural Research, Education and Priority Populations, AHRQ, 540 Gaither Road, Suite 2000, Rockville, Maryland 20850, Telephone (301) 427–1554. Agenda items for these meetings are subject to change as priorities dictate. Dated: January 21, 2010. Carolyn M. Clancy, Director. limitations imposed by the review and funding cycle. Name of Committee: Center for Scientific Review Special Emphasis Panel, Member Conflict: Stroke, Traumatic Brain Injury, and Neurovascular Pathologies. Date: February 25, 2010. Time: 1 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Kevin Walton, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5200, MSC 7846, Bethesda, MD 20892, 301–435– 1785, kevin.walton@nih.hhs.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: January 26, 2010. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2010–1880 Filed 1–29–10; 8:45 am] BILLING CODE 4160–90–M [FR Doc. 2010–2032 Filed 1–29–10; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4140–01–P National Institutes of Health DEPARTMENT OF HEALTH AND HUMAN SERVICES Center for Scientific Review; Notice of Closed Meetings National Institutes of Health jlentini on DSKJ8SOYB1PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel, SRO Conflict SEP: Vector Biology. Date: February 11, 2010. Time: 2 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: The Fairmont San Francisco, 950 Mason Street, San Francisco, CA 94108. Contact Person: John C. Pugh, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 1206, MSC 7808, Bethesda, MD 20892, (301) 435– 2398, pughjohn@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing VerDate Nov<24>2008 18:35 Jan 29, 2010 Jkt 220001 National Cancer Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel. Application of Emerging Technologies and Biospecimen Sciences. Date: February 24–25, 2010. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. PO 00000 Frm 00060 Fmt 4703 Sfmt 4703 Contact Person: Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Boulevard, Room 8059, Bethesda, MD 20892– 8329, 301–496–7904, decluej@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel. R13 Conference Grants Review, Date: February 25, 2010. Time: 1 p.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6116 Executive Boulevard, Room 8041, Rockville, MD 20852 (Telephone Conference Call). Contact Person: Bratin K. Saha, PhD, Scientific Review Officer, Program Coordination and Referral Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Boulevard, Room 8041, Bethesda, MD 20892, 301–402– 0371. sahab@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel, Quantitative Cell-Based Imaging for Clinical Diagnosis and Treatment. Date: February 25, 2010. Time: 12 p.m. to 4 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, 6116 Executive Boulevard, Room 706, Rockville, MD 20852 (Teleconference Meeting). Contact Person: Kenneth L. Bielat, PhD, Scientific Review Officer, Special Review Logistics Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Boulevard, Room 7147, Bethesda, MD 20892–8329, 301–496–7576, bielatk@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; Facilitating the Transfer of Statistical Methodology into Practice. Date: March 3, 2010. Time: 11 a.m. to 3 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, 6116 Executive Boulevard, Room 707, Rockville, MD 20852 (Telephone Conference Meeting). Contact Person: Marvin L Salin, PhD, Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Boulevard, Room 7073, Bethesda, MD 20892–8329 301–496–0694, msalin@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel, Development of Cancer Proteomics Reagents, Date: March 9, 2010. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate contract proposals. Place: The Legacy Hotel and Meeting Center, 1775 Rockville Pike, Rockville, MD 20852, Contact Person: Zhiqiang Zou, M.D., PhD, Scientific Review Officer, National Cancer Institute, National Institutes of Health, 6116 Executive Blvd., Room 8050A, Bethesda, MD 20852, 301–402–9415, zouzhiq@mail.nih.gov. E:\FR\FM\01FEN1.SGM 01FEN1 jlentini on DSKJ8SOYB1PROD with NOTICES Federal Register / Vol. 75, No. 20 / Monday, February 1, 2010 / Notices Name of Committee: National Cancer Institute Special Emphasis Panel, Innovative Technologies Development. Date: March 10–11, 2010. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Jeffrey E. DeClue, PhD, Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Boulevard, Room 8059, Bethesda, MD 20892–8329, 301–496–7904, decluej@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel, EDRN Biomarker Development Labs (U01). Date: March 10–11, 2010. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 20814. Contact Person: Sherwood Githens, PhD, Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Blvd. Room 8146, Bethesda, MD 20892, 301–435–1822, githenss@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; Development of Anticancer Agents. Date: March 24–26, 2010. Time: 8:30 a.m. to 5 p.m. Agenda: To review and evaluate contract proposals. Place: Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Road, Bethesda, MD 20852. Contact Person: Joyce C. Pegues, PhD, Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, NIH National Cancer Institute, 6116 Executive Boulevard, Room 7149, Bethesda, MD 20892–8329, 301–594–1286, peguesj@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; Cancer Nanotechnology Platform Partnerships. Date: March 31–April 1, 2010. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda North Marriott Hotel & Conference Center, Montgomery County Conference Center Facility, 5701 Marinelli Road, North Bethesda, MD 20852. Contact Person: Savvas C Makrides, PhD, Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Blvd., Rm 8053, Bethesda, MD 20892, 301–496–7421, makridessc@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel, Small Grants Program for Cancer Epidemiology. Date: April 15–16, 2010. Time: 8:30 a.m. to 5:30 p.m. Agenda: To review and evaluate grant applications. VerDate Nov<24>2008 18:35 Jan 29, 2010 Jkt 220001 Place: Legacy Hotel and Meeting Center, 1775 Rockville Pike, Rockville, MD 20852. Contact Person: Joyce C. Pegues, PhD, Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Boulevard, Room 7149, Bethesda, MD 20892–8329, 301–594–1286, peguesj@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: January 25, 2010. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. 5093 Review, Group Neurological Sciences and Disorders A. Date: March 3, 2010. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Argonaut Hotel, 495 Jefferson Street, San Francisco, CA 94109. Contact Person: Richard D. Crosland, PhD, Scientific Review Officer, Scientific Review Branch, Division of Extramural Research, NINDS/NIH/DHHS, Neuroscience Center, 6001 Executive Blvd., Suite 3208, MSC 9529, Bethesda, MD 20892–9529, 301–496–9223. (Catalogue of Federal Domestic Assistance Program Nos. 93.853, Clinical Research Related to Neurological Disorders; 93.854, Biological Basis Research in the Neurosciences, National Institutes of Health, HHS) [FR Doc. 2010–2030 Filed 1–29–10; 8:45 am] Dated: January 25, 2010. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. BILLING CODE 4140–01–P [FR Doc. 2010–1932 Filed 1–29–10; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Neurological Disorders and Stroke; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Neurological Disorders and Stroke Initial Review Group, Neurological Sciences and Disorders B. Date: February 25–26, 2010. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: US Grant Hotel, 326 Broadway, San Diego, CA 92101. Contact Person: Ernest W Lyons, PhD, Scientific Review Officer, Scientific Review Branch, NINDS/NIH/DHHS, Neuroscience Center, 6001 Executive Blvd., Suite 3208, MSC 9529, Bethesda, MD 20892–9529, 301– 496–4056. Name of Committee: National Institute of Neurological Disorders and Stroke Initial PO 00000 Frm 00061 Fmt 4703 Sfmt 4703 Agency for Healthcare Research and Quality Notice of Meeting In accordance with section 10(d) of the Federal Advisory Committee Act (5 U.S.C., Appendix 2), announcement is made of a Health Care Policy and Research Special Emphasis Panel (SEP) meeting. A Special Emphasis Panel is a group of experts in fields related to health care research who are invited by the Agency for Healthcare Research and Quality (AHRQ), and agree to be available, to conduct on an as-needed basis, scientific reviews of applications for AHRQ support. Individual members of the Panel do not attend regularly scheduled meetings and do not serve for fixed terms or a long period of time. Rather, they are asked to participate in particular review meetings which require their type of expertise. Substantial segments of the upcoming SEP meeting listed below will be closed to the public in accordance with the Federal Advisory Committee Act, section 10(d) of 5 U.S.C., Appendix 2 and 5 U.S.C. 552b (c)(6). Grant applications for the ARRA: Limited Competition ‘‘Electronic Data Methods’’ (U13) applications are to be reviewed and discussed at this meeting. These discussions are likely to reveal personal information concerning individuals associated with the applications. This information is exempt from mandatory E:\FR\FM\01FEN1.SGM 01FEN1

Agencies

[Federal Register Volume 75, Number 20 (Monday, February 1, 2010)]
[Notices]
[Pages 5092-5093]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-2030]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and/or contract proposals 
and the discussions could disclose confidential trade secrets or 
commercial property such as patentable material, and personal 
information concerning individuals associated with the grant 
applications and/or contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel. Application of Emerging Technologies and Biospecimen 
Sciences.
    Date: February 24-25, 2010.
    Time: 8 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: Scientific Review Officer, Special Review and 
Logistics Branch, Division of Extramural Activities, National Cancer 
Institute, NIH, 6116 Executive Boulevard, Room 8059, Bethesda, MD 
20892-8329, 301-496-7904, decluej@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel. R13 Conference Grants Review,
    Date: February 25, 2010.
    Time: 1 p.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6116 Executive Boulevard, 
Room 8041, Rockville, MD 20852 (Telephone Conference Call).
    Contact Person: Bratin K. Saha, PhD, Scientific Review Officer, 
Program Coordination and Referral Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 6116 Executive 
Boulevard, Room 8041, Bethesda, MD 20892, 301-402-0371. 
sahab@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Quantitative Cell-Based Imaging for Clinical Diagnosis and 
Treatment.
    Date: February 25, 2010.
    Time: 12 p.m. to 4 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 6116 Executive Boulevard, 
Room 706, Rockville, MD 20852 (Teleconference Meeting).
    Contact Person: Kenneth L. Bielat, PhD, Scientific Review 
Officer, Special Review Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, 6116 Executive Boulevard, 
Room 7147, Bethesda, MD 20892-8329, 301-496-7576, 
bielatk@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Facilitating the Transfer of Statistical Methodology into 
Practice.
    Date: March 3, 2010.
    Time: 11 a.m. to 3 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 6116 Executive Boulevard, 
Room 707, Rockville, MD 20852 (Telephone Conference Meeting).
    Contact Person: Marvin L Salin, PhD, Scientific Review Officer, 
Special Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 6116 Executive 
Boulevard, Room 7073, Bethesda, MD 20892-8329 301-496-0694, 
msalin@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Development of Cancer Proteomics Reagents,
    Date: March 9, 2010.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: The Legacy Hotel and Meeting Center, 1775 Rockville Pike, 
Rockville, MD 20852,
    Contact Person: Zhiqiang Zou, M.D., PhD, Scientific Review 
Officer, National Cancer Institute, National Institutes of Health, 
6116 Executive Blvd., Room 8050A, Bethesda, MD 20852, 301-402-9415, 
zouzhiq@mail.nih.gov.


[[Page 5093]]


    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Innovative Technologies Development.
    Date: March 10-11, 2010.
    Time: 8 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: Jeffrey E. DeClue, PhD, Scientific Review 
Officer, Special Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 6116 Executive 
Boulevard, Room 8059, Bethesda, MD 20892-8329, 301-496-7904, 
decluej@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, EDRN Biomarker Development Labs (U01).
    Date: March 10-11, 2010.
    Time: 8 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 
20814.
    Contact Person: Sherwood Githens, PhD, Scientific Review 
Officer, Special Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, 6116 Executive Blvd. Room 
8146, Bethesda, MD 20892, 301-435-1822, githenss@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Development of Anticancer Agents.
    Date: March 24-26, 2010.
    Time: 8:30 a.m. to 5 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, Bethesda, MD 20852.
    Contact Person: Joyce C. Pegues, PhD, Scientific Review Officer, 
Special Review and Logistics Branch, Division of Extramural 
Activities, NIH National Cancer Institute, 6116 Executive Boulevard, 
Room 7149, Bethesda, MD 20892-8329, 301-594-1286, 
peguesj@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Cancer Nanotechnology Platform Partnerships.
    Date: March 31-April 1, 2010.
    Time: 8 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 
Montgomery County Conference Center Facility, 5701 Marinelli Road, 
North Bethesda, MD 20852.
    Contact Person: Savvas C Makrides, PhD, Scientific Review 
Officer, Special Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 6116 Executive Blvd., Rm 
8053, Bethesda, MD 20892, 301-496-7421, makridessc@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Small Grants Program for Cancer Epidemiology.
    Date: April 15-16, 2010.
    Time: 8:30 a.m. to 5:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Legacy Hotel and Meeting Center, 1775 Rockville Pike, 
Rockville, MD 20852.
    Contact Person: Joyce C. Pegues, PhD, Scientific Review Officer, 
Special Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 6116 Executive 
Boulevard, Room 7149, Bethesda, MD 20892-8329, 301-594-1286, 
peguesj@mail.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: January 25, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-2030 Filed 1-29-10; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.